In vivo data show Evusheld retains neutralizing activity against Omicron SARS-CoV-2 BA.2 subvariant March 22, 2022
Ceftibuten/VNRX-7145 shows efficacy against Enterobacterales carrying common serine beta-lactamases March 18, 2022